<DOC>
	<DOCNO>NCT01733368</DOCNO>
	<brief_summary>Optimization evolution patient evaluate 6 month implant .</brief_summary>
	<brief_title>QUARTO-II Study Evaluate Management Patients Resynchronized With QuartetTM LV Quadripolar Lead</brief_title>
	<detailed_description>Patient enrol study Informed Consent signature CRT-D+quadripolar ( QuartetTM ) LV lead .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient implant CRTD device QuartetTM quadripolar lead St. Jude Medical leave ventricle . Patient echocardiographic study perform 1 month prior implant End Systolic Volume Left Ventricle ( LVESV ) measure Patients grant informed consent . Patients 18 year . Patients previously resynchronized . Patients aortic stenosis aortic valve prosthesis Patients may potentially pregnant . Patients life expectancy &lt; 12 month . Patients attend monitor visit establish protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CRT</keyword>
	<keyword>Optimization</keyword>
	<keyword>Responders</keyword>
</DOC>